Eckert & Ziegler Strahlen- und Medizintechnik AG

Regulatory Filings • Aug 7, 2008

News Details

Corporate | 7 August 2008 13:23

Eckert & Ziegler Isotope Products announces new 5 year distribution agreement with Cardinal Health

ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Contract

Release of a Corporate News, transmitted by DGAP - a company of EquityStory
AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

Valencia, California, USA, August 7, 2008 - Eckert & Ziegler Isotope
Products (EZIP) has successfully extended, for another five years, its
existing distribution agreement with Cardinal Health Inc., one of the
largest operators of Nuclear Pharmacies in North America. Cardinal Health
will market the full line of EZIP Medical imaging products in the U.S,
including calibration and reference sources for imaging applications, such
as PET (Positron Emission Tomography), SPECT (Single Photon Emission
Computed Tomography), and multi modality applications. The Dublin, Ohio
based company will also market EZIP's flexible Cobalt-57 flood source,
Perflexion.

Known for its broad portfolio of products, EZIP has become the world's
leading supplier of Nuclear Medicine calibration standards. Recent
innovations such as the new Soft Sided storage case for the WolfGuardTM
shield have put EZIP at the forefront of Nuclear Medicine source and
shielding development.

EZIP sells its products via various avenues, including direct to users,
international distributors in over 30 countries and in partnerships with
original equipment manufacturers.

About Eckert & Ziegler Isotope Products

For over forty (40) years, Eckert & Ziegler Isotope Products, (a subsidiary
of Eckert & Ziegler AG) has been producing instrumentation and calibration
standards. Today it is the world's leading manufacturer for nuclear
imaging reference and calibration standards and a leading producer of
radioactive components for industrial, scientific and medical applications.

Eckert & Ziegler AG is a global isotope technology company that processes
radioisotopes as well as develops, manufactures and sells isotope
technology components, medical technology equipment and related products.
The group employs about 430 people worldwide. Throughout all of its
subsidiaries it generates yearly consolidated revenues in excess of $ 100
MM (70 Mio. EUR). Eckert & Ziegler AG is listed in the Prime Standard of
the German Stock Exchange in Frankfurt am Main (ISIN DE0005659700).

The Executive Board

Eckert & Ziegler Isotope Products Inc.

Valencia, California 91355
T: 661.309.1010
F. 661.257.8308

Media contact:
Melanie Harrison
T: 661.309.1060
E : melanie.harrison@ezag.com

Alternative European contact:

Eckert & Ziegler Isotope Products GmbH
Robert-Rössle-Strasse 10
D-13125 Berlin-Buch
Germany
T: +44 (0) 30.94.10.84.0
F: +49 (0) 30.94.10.84.320
E: martin.hughes@ezag.com

07.08.2008 Financial News transmitted by DGAP

Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10
13125 Berlin
Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: thomas.scheuch@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, München, Hamburg, Düsseldorf

End of News DGAP News-Service

---